RELATIONSHIP BETWEEN UNBOUND PLASMA-CONCENTRATIONS AND VARIOUS PSYCHOMOTOR AND SUBJECTIVE EFFECTS AFTER INTAKES OF DIAZEPAM AND FLUNITRAZEPAM

被引:14
作者
INGUM, J [1 ]
PETTERSEN, G [1 ]
SAGER, G [1 ]
MORLAND, J [1 ]
机构
[1] INST MED BIOL,DEPT PHARMACOL,N-9037 TROMSO,NORWAY
关键词
FLUNITRAZEPAM; IN-VIVO POTENCY; PSYCHOMOTOR EFFECTS; UNBOUND PLASMA CONCENTRATION;
D O I
10.1097/00004850-199400920-00008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Unbound plasma concentrations of diazepam and flunitrazepam were related to psychomotor and subjective effects of the two drugs. The interindividual variability in plasma protein binding of both diazepam (98.5 +/- 0.14%) and flunitrazepam (84.5 +/- 1.2%) was relatively small, and high correlations were therefore observed between the individual unbound and total drug plasma concentrations after a particular dose. However, poor correlations were seen between individual unbound drug plasma concentrations and psychomotor or subjective effects. This observation indicates that factors other than individual variability in drug plasma concentration, account for the pronounced individual differences in, for example, psychomotor impairment frequently observed after intake of benzodiazepines. Furthermore, based on a linear relationship between unbound drug plasma concentrations and increase in either complex choice or simple reaction time, the potency of flunitrazepam was calculated to be about seven times higher than the potency of diazepam. This is approximately two times higher than expected from the reported in vitro affinity of the two drugs for the benzodiazepine receptor. This finding may indicate that flunitrazepam may have a higher apparent in vivo intrinsic efficacy than diazepam when assessed by psychomotor impairment.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 28 条
[1]  
ABEL JG, 1979, CLIN PHARMACOL THER, V26, P247
[2]   COMPARATIVE PROTEIN-BINDING OF DIAZEPAM AND DESMETHYLDIAZEPAM [J].
ALLEN, MD ;
GREENBLATT, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (5-6) :219-223
[3]  
ARENDT RM, 1983, J PHARMACOL EXP THER, V227, P98
[4]   PHARMACOLOGICAL CHARACTERIZATION OF BENZODIAZEPINE RECEPTORS IN BRAIN [J].
BRAESTRUP, C ;
SQUIRES, RF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 48 (03) :263-270
[6]   PLASMA-BINDING AND TRANSPORT OF DIAZEPAM ACROSS THE BLOOD-BRAIN-BARRIER - NO EVIDENCE FOR INVIVO ENHANCED DISSOCIATION [J].
DUBEY, RK ;
MCALLISTER, CB ;
INOUE, M ;
WILKINSON, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1155-1159
[7]  
FACKLAM M, 1992, J PHARMACOL EXP THER, V261, P1106
[8]  
FACKLAM M, 1992, J PHARMACOL EXP THER, V261, P1113
[9]   PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL DIAZEPAM - EFFECT OF DOSE, PLASMA-CONCENTRATION, AND TIME [J].
FRIEDMAN, H ;
GREENBLATT, DJ ;
PETERS, GR ;
METZLER, CM ;
CHARLTON, MD ;
HARMATZ, JS ;
ANTAL, EJ ;
SANBORN, EC ;
FRANCOM, SF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (02) :139-150
[10]  
GJERDE H, 1902, J PHARM BIOMEDICAL A, V10, P317